• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cidara Therapeutics, Inc. - Common Stock (NQ:CDTX)

62.90 -0.41 (-0.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 302,041
Open 62.18
Bid (Size) 60.00 (1)
Ask (Size) 64.00 (2)
Prev. Close 63.31
Today's Range 61.90 - 64.25
52wk Range 10.14 - 66.94
Shares Outstanding 49,506,268
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
June 30, 2025
With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories? 
Via MarketBeat
FedEx Issues Soft Guidance, Joins Torrid Holdings, Allot And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 25, 2025
 
Via Benzinga

Performance

YTD
+130.4%
+130.4%
1 Month
+28.9%
+28.9%
3 Month
+192.6%
+192.6%
6 Month
+231.9%
+231.9%
1 Year
+429.5%
+429.5%

More News

Read More
Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 25, 2025
Via Benzinga
Applied Materials To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Tuesday
June 24, 2025
Via Benzinga
Earnings Scheduled For May 8, 2025
May 08, 2025
Via Benzinga
Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offering
June 23, 2025
Via Stocktwits
What's going on in today's session
June 23, 2025
Via Chartmill
Cidara Therapeutics’ Market Cap Doubles After Investigational Drug Shows Positive Results In Preventing Influenza In Mid-stage Trial
June 23, 2025
Via Stocktwits
12 Health Care Stocks Moving In Monday's Intraday Session
June 23, 2025
Via Benzinga
Crude Oil Falls 1%; US Services PMI Declines In June
June 23, 2025
Via Benzinga
Which stocks are experiencing notable movement on Monday?
June 23, 2025
Via Chartmill
Cidara Launches 93% As A Universal Flu Shot Becomes A Closer Reality
June 23, 2025
Via Investor's Business Daily
Why Is Cidara Therapeutics Stock Trading Higher On Monday?
June 23, 2025
Via Benzinga
Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results
June 23, 2025
Via Benzinga
Topics Stocks
These stocks are gapping in today's session
June 23, 2025
Via Chartmill
These stocks are moving in today's pre-market session
June 23, 2025
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 23, 2025
Via Benzinga
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors
April 16, 2025
From Phathom Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via Benzinga
Cidara Therapeutics' Unique Cloudbreak Platform And Its Promise In Influenza And Oncology
November 14, 2024
Via Talk Markets
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
November 08, 2024
Via Benzinga
CDTX Stock Earnings: Cidara Therapeutics Beats EPS, Misses Revenue for Q2 2024
August 13, 2024
Via InvestorPlace
CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
May 16, 2024
Via NewMediaWire
Topics Regulatory Compliance
CDTX INVESTOR NOTICE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX
May 16, 2024
Via TheNewswire.com
Topics Regulatory Compliance
CDTX Stock Earnings: Cidara Therapeutics Misses EPS, Misses Revenue for Q1 2024
May 15, 2024
Via InvestorPlace

Frequently Asked Questions

Is Cidara Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cidara Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cidara Therapeutics, Inc. - Common Stock trade on?
Cidara Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cidara Therapeutics, Inc. - Common Stock?
The ticker symbol for Cidara Therapeutics, Inc. - Common Stock is CDTX on the Nasdaq Stock Market
What is the current price of Cidara Therapeutics, Inc. - Common Stock?
The current price of Cidara Therapeutics, Inc. - Common Stock is 62.90
When was Cidara Therapeutics, Inc. - Common Stock last traded?
The last trade of Cidara Therapeutics, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of Cidara Therapeutics, Inc. - Common Stock?
The market capitalization of Cidara Therapeutics, Inc. - Common Stock is 3.11B
How many shares of Cidara Therapeutics, Inc. - Common Stock are outstanding?
Cidara Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap